BusinessTreos Bio Announces Activation of U.S. Clinical Trial Site for Phase 1 Study of PolyPEPI™ Precision Cancer Vaccine for Patients with Metastatic Colorectal CancerBy Nasdaq OMXApr 11, 2018, 12:15 PM UTC
BusinessNanoString Announces Launch of Breast Cancer 360 Research Panel, Expanding the 360 Series of Cancer Panels for Translational Research and Signature DevelopmentBy Nasdaq OMXApr 10, 2018, 8:01 PM UTC
BusinessAdaptimmune to Present Two Posters at the Upcoming American Association for Cancer Research (AACR) Annual MeetingBy Nasdaq OMXApr 6, 2018, 12:00 PM UTC
BusinessCrownBio to Showcase Scientific Expertise in Preclinical Drug Development at the American Association for Cancer Research (AACR) ConferenceBy Nasdaq OMXApr 4, 2018, 12:00 PM UTC
BusinessTreos Bio Names Gábor Illés as Its Chief Financial OfficerBy Nasdaq OMXApr 3, 2018, 12:15 PM UTC
BusinessRitter Pharmaceuticals Announces 1-for-10 Reverse Stock SplitBy Nasdaq OMXMar 22, 2018, 3:35 PM UTC
BusinessCBT Pharmaceuticals to Grow Immuno-Oncology Pipeline by License Agreement of CrownBio CTLA-4 AntibodyBy Nasdaq OMXMar 22, 2018, 1:34 PM UTC
BusinessRitter Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business UpdateBy Nasdaq OMXMar 19, 2018, 10:35 AM UTC
